T he U.S. Food and Drug Administration has banned the use of red dye No. 3 in foods, more than three decades after ...

The global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, is forecasted to grow at a robust CAGR of ...

Comet announces that it has received FODMAP Friendly certification. COMET submitted its patented Arrabina® prebiotic dietary ...

Glucotrack, Inc. (NASDAQ: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently developing a long-term implantable ...